Thursday, July 15, 2010

NEW for 2010 continued

PCA3 urine test A specific urine test to stratify patients having elevated PSA's at risk for prostate cancer. The specimen is collected and prepared in the office before it is processed at a specialized laboratory. The results are returned to our office usually within 48-72 hours.

Gardasil vaccine for men. In 10/09, the FDA approved Gardasil for boys and men 9-26 years of age for the prevention of genital warts. The vaccine is available in our office for administration.

Greenlight laser for BPH (benign prostate enlargement) The numbers of procedures for this successful outpatient modality continue to increase as patient satisfaction and "word of mouth" are the guiding forces directing patients away from the traditional TURP (transurethral resection of the prostate).

Bladder outlet and prostate enlargement Medications to treat the prostate continue to enter the market offering patients more options to treat non-invasively. Flomax, Uroxatral and now Rapaflo, a new entry is available in the pharmacological treatment of poor urinary flow secondary to prostate enlargement.

Urgency incontinence The market is flooded with a range of choices. Older medications include ditropan, oxytrol, enablex and detrol. Newer entries include Vesicare, Sanctura and now Toviaz and Gelnique offer patients more options.

No comments:

Post a Comment